GENE ONLINE|News &
Opinion
Blog

Interviews
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
From Taiwan Fungi to the Global Antimicrobial Market: Dr. George Tsai’s Journey of Innovation at AMS BioteQ
2024-11-20
Hiroaki Ueno: Leading Japan’s Pharma Revolution with Innovation and Global Strategy
2024-11-12
Japan’s Bio-Economy Push: A Future Driven by Innovation and Global Collaboration
2024-11-12
Promoting Sustainability: AMATA’s Commitment to Eco-Friendly Practices in Globalizing Thailand’s Local Footprint
2024-10-15
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
AusBiotech on Funding, Regulatory Navigation, International Expansion, and Clinical Trial Development in Australia’s Biotech Industry
2024-08-22
Reshaping the Genetic Testing Landscape with Quantum Computing: Dr. Anmol Kapoor, CEO of BioAro
2024-08-13
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
1 2 3 6
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
Gilead Strikes Again: $415M Bet on ADCs with Tubulis Deal
2024-12-03
EVENT
Scroll to Top